Literature DB >> 8513579

Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness.

N Lahat1, R Shtiller, A Y Zlotnick, G Merin.   

Abstract

High serum level of immunoreactive but not biologically active IL-2 was detected 1 day after surgery in patients undergoing major operation (abdominal, open-heart), in proportion to the tissue injury caused by surgical trauma. IL-2 values were highest in those patients who underwent open-heart surgery and received blood transfusions. In all patients they declined in the third and fourth post-operative days. Elevated serum levels of soluble IL-2 receptors (sIL-2R) were already present 1 day after operation, and peaked in the third and fifth post-operative days after mitogen triggering. Blood lymphocytes derived from operated patients secreted reduced amounts of both IL-2 and sIL-2R compared with control lymphocytes. The extent and duration of this reduction were also proportional to the tissue trauma and were affected by blood transfusions. Based on these data we suggest that early post-operative systemic immunological activation (appearance of IL-2 in the serum) is followed by elevation of sIL-2R, which then interferes with IL-2-dependent immunity. Blood lymphocytes are probably not involved in the post-operative immunological activation. The trigger for and the site of IL-2/sIL-2R synthesis are not yet clear.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513579      PMCID: PMC1554783          DOI: 10.1111/j.1365-2249.1993.tb03425.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome.

Authors:  K K Sethi; H Näher
Journal:  Immunol Lett       Date:  1986-10       Impact factor: 3.685

2.  Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody.

Authors:  G J Nau; R L Moldwin; D W Lancki; D K Kim; F W Fitch
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

3.  The effect of cardiopulmonary bypass on T cells and their subpopulations.

Authors:  H Ide; T Kakiuchi; N Furuta; H Matsumoto; K Sudo; A Furuse; K Asano
Journal:  Ann Thorac Surg       Date:  1987-09       Impact factor: 4.330

4.  Immunosuppressive effect of surgery.

Authors:  S K Park; J I Brody; H A Wallace; W S Blakemore
Journal:  Lancet       Date:  1971-01-09       Impact factor: 79.321

5.  Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.

Authors:  M Chilosi; G Semenzato; G Cetto; A Ambrosetti; L Fiore-Donati; G Perona; G Berton; M Lestani; A Scarpa; C Agostini
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

6.  Plasma interleukin 2 receptor levels in renal allograft recipients.

Authors:  R B Colvin; T C Fuller; L MacKeen; P C Kung; S H Ip; A B Cosimi
Journal:  Clin Immunol Immunopathol       Date:  1987-05

7.  Soluble interleukin-2 receptors in systemic lupus erythematosus.

Authors:  R E Wolf; W G Brelsford
Journal:  Arthritis Rheum       Date:  1988-06

8.  The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.

Authors:  G Vitale; G Reina; S Mansueto; R Malta; G Gambino; C Mocciaro; R D'Agostino; M Dieli; E Cillari
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

9.  Effect of blood transfusion on antigen presentation function and on interleukin 2 generation.

Authors:  R N Stephan; J M Kisala; R E Dean; A S Geha; I H Chaudry
Journal:  Arch Surg       Date:  1988-02

10.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  3 in total

1.  Abdominal surgery reduces the ability of rat spleen cells to synthesize and secrete active tumour necrosis factor-alpha (TNF-alpha) by a multilevel regulation.

Authors:  N Lahat; M A Rahat; V Brod; S Cohen; G Weber; A Kinarty; H Bitterman
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  A Roth-Isigkeit; L Hasselbach; E Ocklitz; S Brückner; A Ros; H Gehring; P Schmucker; L Rink; M Seyfarth
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

3.  Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells.

Authors:  A D Roth; S Dupuis; P Alberto
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.